CellaVision AB (STU:C26) Margin of Safety % (DCF Dividends Based) : 9.01% (As of May. 11, 2025)

View and export this data going back to 2017. Start your Free Trial

What is CellaVision AB Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2025-05-11), CellaVision AB's Predictability Rank is 4-Stars. CellaVision AB's intrinsic value calculated from the Discounted Dividend model is €14.16 and current share price is €17.68. Consequently,

CellaVision AB's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 9.01%.

Competitive Comparison of CellaVision AB's Margin of Safety % (DCF Dividends Based)

For the Medical Devices subindustry, CellaVision AB's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellaVision AB's Margin of Safety % (DCF Dividends Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Margin of Safety % (DCF Dividends Based) falls into.

Save Embed

;

Save Embed

;

CellaVision AB Margin of Safety % (DCF Dividends Based) Calculation

CellaVision AB's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)	=	(Intrinsic Value: DCF (Dividends Based)	-	Current Price)	/	Intrinsic Value: DCF (Dividends Based)
	=	(19.43	-	17.68)	/	19.43
	=	9.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

CellaVision AB Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (STU:C26) » Definitions » Margin of Safety % (DCF Dividends Based)

Comparable Companies

Traded in Other Exchanges

CEVI:Sweden 0MR5:UK CEVIs:UK

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines